Regenics vs Telos Rx: Compounded GLP-1 Pricing and Care
Quick verdict: Regenics vs Telos Rx for compounded GLP-1s
The short answer: Telos Rx lists lower entry prices for compounded semaglutide and tirzepatide, while Regenics pairs mid-pack promotional pricing with a nurse-practitioner model and a Sermorelin add-on. Both require review by a licensed clinician and both offer compounded medications that are not FDA-approved.
See Regenics pricing and clinician review
How their pricing and promotional terms compare
Pricing is a primary distinction in the Regenics vs Telos Rx comparison. Regenics advertises compounded semaglutide at $139 for the first month and tirzepatide at $189 for the first month, with stated renewals of $199 and $279. Telos Rx presents semaglutide as low as $99 per month and tirzepatide as low as $139 per month, with language that individual price depends on approval and plan. Regenics documents the first month promotional price explicitly; Telos Rx emphasizes “as low as” pricing and that price may depend on approval.
Check Telos Rx current offers and eligibility
Five-point comparison table
| Criteria | Regenics | Telos Rx |
|---|---|---|
| Starting semaglutide price | $139 first month | As low as $99 per month |
| Starting tirzepatide price | $189 first month | As low as $139 per month |
| Who reviews prescriptions | Licensed nurse practitioners review intake | US licensed provider reviews and approves |
| Medication type | Compounded semaglutide and tirzepatide; Sermorelin add-on | Compounded semaglutide and tirzepatide |
| Regulatory note | Compounded meds not FDA-approved | Compounded meds not FDA-approved |
| Pharmacy network | LegitScript certified pharmacy network stated | Pharmacy and state coverage may vary; not fully published |
Clinician oversight and eligibility
Both providers require a licensed clinician to determine whether treatment is medically appropriate. Regenics specifically notes nurse-practitioner-led care where licensed nurse practitioners review intake before prescribing. Telos Rx states a US-licensed provider decides which medication is right and that treatment is subject to medical approval. Neither page supplies full details on telehealth workflows beyond clinician review.
Review Regenics clinician process
Medication status, safety, and pharmacy claims
Both sources clearly state their GLP-1 options are compounded medications and include the regulatory qualifier that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Regenics adds that the pharmacy network is LegitScript certified and that medications are compounded by U.S. licensed pharmacies and shipped free. Telos Rx highlights the molecule differences in mechanism, noting semaglutide acts on GLP-1 while tirzepatide acts on GLP-1 plus GIP, and reiterates that compounded meds are prescription-only and not FDA-approved.
Compare Telos Rx prescribing details
Extra features, renewals, and transparency
Regenics markets a Sermorelin peptide add-on and states free shipping and FSA/HSA eligibility. It also discloses that promotional pricing applies to the first month and that renewals increase to stated renewal amounts. Telos Rx emphasizes “as low as” pricing and repeatedly notes that final price, eligibility, pharmacy, state coverage and renewal terms may change and are subject to the live offer. The captured Telos Rx evidence does not publish full renewal specifics on the captured page.
Conclusion: Regenics vs Telos Rx
In short, choose Telos Rx if your primary goal is the lowest advertised entry price for compounded semaglutide or tirzepatide and you will confirm the final price and eligibility with the provider. Choose Regenics if you value a nurse-practitioner-led intake, an explicitly stated first-month promotional price with published renewal amounts, and the option of a Sermorelin peptide add-on. Remember both require licensed clinician review and both provide compounded medications that are not FDA-approved.
Choose Regenics if you want nurse-practitioner care and a Sermorelin option